The Precision Medicine Molecular Tumor Board (PMMTB) is a statewide service available to oncologists at UW Health and within the Wisconsin Oncology Network (WON).
The Precision Medicine Molecular Tumor Board works in partnership with the UW Collaborative Genomics Core and the UW Carbone Cancer Center (UWCCC).
The PMMTB provides a forum for expert clinicians, pathologists and scientists to discuss and analyze tumor genotypes and molecular abnormalities in order to recommend patient specific targeted therapies.
The PMMTB is intended to supplement oncology tumor boards and includes a broad range of expert panel members.
Clinicians can order a genomic report and submit a case study to be presented for review by the PMMTB during their twice monthly meetings.